Managing people with opioid-use disorder in the emergency departmentCanadian Association of Emergency Physicians offers recommendations for emergency healthcare providers to help address Canada’s opioid crisis. Nonbenzodiazepine hypnotic, Lunesta (eszopiclone) now marketed in Canada Approved for short-term use in adults with difficulty falling asleep, or nocturnal or early morning awakenings. Provide families with guidance on how to reset sleep times disrupted by COVID-19 Pandemic has significantly altered normal sleep patterns for children and teenagers Spravato, a new intranasal treatment for resistant depression Intended for patients who have not responded adequately to at least two different antidepressants Scientists get closer to blood test for Alzheimer's disease The testing identified people with Alzheimer's vs. no dementia or other types of it with accuracy ranging from 89% to 98% Consider long-acting injectable antipsychotics more often in early-phase schizophrenia Study reports significant delay in time to hospitalization compared to usual care when LAIAs are used in patients with early-phase schizophrenia Q&A: Antidepressants now Psychiatrist Dr. Jon Davine’s advice for FPs on optimizing antidepressant dose, switching and augmenting Overdiagnosed, overtreated For decades psychiatrists have argued over the boundaries between pathology and normality. Are we any closer to an answer? Beyond the baby blues How pharmacists can help women struggling with postpartum depression Depressive symptoms with oral contraceptives Adolescents, but not adult women, appear to be at increased risk for depressive symptoms when taking OCPs First Previous 24 25 26 27 28 Next Last
